Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
03/2014
03/13/2014WO2014037342A1 Herbicidally active bicycloaryl carboxylic acid amides
03/13/2014WO2014037327A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof
03/13/2014US20140073782 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
03/13/2014US20140073760 Use of an ang-(1-7) receptor agonist in acute lung injury
03/13/2014US20140073679 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
03/13/2014US20140073669 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
03/13/2014US20140073668 N-quinolin-benzensulfonamides and related compounds for the treatment of cancer, autoimmune disorders and inflammation
03/13/2014US20140073666 Compositions and methods for treatment
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/13/2014US20140073621 5-alkynyl-pyrimidines
03/12/2014CN103635464A Polyphenylene host compounds
03/12/2014CN103626742A Bi-aryl meta-pyrimidine inhibitors of kinases
03/12/2014CN103626692A 3,5-diaryl-ylidene piperidone derivatives and application thereof in preparing blood glucose-reducing and fat-reducing medicine
03/12/2014CN102869656B Tetrahydrobenzothiophene compound
03/12/2014CN101720318B Quinazolin-oxime derivatives as Hsp90 inhibitors
03/12/2014CN101641332B Derivatives of aminated hydroxyquinoline class for treating cancers
03/11/2014US8669381 Chromone inhibitors of S-nitrosoglutathione reductase
03/11/2014US8669234 Antiviral compounds
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/06/2014WO2014034898A1 Pyridine derivative and medicine
03/06/2014WO2014034793A1 Aromatic amine derivative, and organic electroluminescent element using same
03/06/2014WO2014034584A1 Organic electroluminescent element, illuminator, and display device
03/06/2014WO2014033448A1 Pyrazole derivatives as p38 map inhibitors
03/06/2014WO2014032801A1 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014WO2013144931A3 Tcr/mhcii-collagen interaction inhibitors useful for the treatment of rheumatoid arthritis
03/06/2014US20140066476 Modulators of cellular adhesion
03/06/2014US20140066466 Necroptosis Inhibitors and Methods of Use Therefor
03/06/2014US20140066457 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
03/06/2014US20140066451 Thioxanthene derivatives for the treatment of infectious diseases
03/06/2014US20140066430 Aurora kinase modulators and method of use
03/06/2014US20140066426 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140065103 Compounds and methods for the treatment or prevention of flaviviridae viral infections
03/05/2014EP2703388A1 Compound with acridan ring structure, and organic electroluminescent element
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014EP2702053A2 Novel rock inhibitors
03/05/2014EP2702052A1 17alpha-hydroxylase/c17,20-lyase inhibitors
03/05/2014EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
03/05/2014CN103619836A Antimicrobial/adjuvant compounds and methods
03/05/2014CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists
03/05/2014CN103619833A Novel compounds for organic electronic material and organic electroluminescent device using the same
03/05/2014CN103619821A Compound with acridan ring structure, and organic electroluminescent element
03/05/2014CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN103613583A 1, 3-substituent-4-substituted pyrazol acylhydrazone derivative and preparation method and application thereof
03/05/2014CN103613551A Synthesis method for substituted triazole compound
03/05/2014CN103613550A Environment-friendly synthesis method for 4(3H)-quinazolinone
03/05/2014CN103613541A Preparation method of tetra-substituted olefin and its pyrazole derivatives
03/05/2014CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN102250006B 3-pyrazole carboxylic acid amide compounds, preparation method thereof and application thereof in preparation of medicament serving as CB1 receptor inhibitor
03/05/2014CN101835757B Diacylglycerol acyltransferase inhibitors
03/05/2014CN101805281B Oxime ester compound and photosensitive polymer composition using same
03/04/2014US8664396 Photoluminescent metal complexes for protein staining
03/04/2014US8664214 Small molecule potentiators of metabotropic glutamate receptors I
02/2014
02/27/2014WO2014031784A1 Compounds for the treatment of paramoxyvirus viral infections
02/27/2014WO2014031581A1 Process for the synthesis of substituted gamma lactams
02/27/2014WO2014030921A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
02/27/2014WO2014030831A1 Compound for organic optoelectric device, organic light-emitting diode including same, and display device including organic light-emitting diode
02/27/2014WO2014030822A1 Compound for organic optoelectronic element, organic light-emitting element comprising same, and display device comprising the organic light-emitting element
02/27/2014WO2014030743A1 Heterocycic compound
02/27/2014WO2014029832A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014WO2014029831A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014WO2014029726A1 Novel phenyl-pyridine/pyrazine amides for the treatment of cancer
02/27/2014WO2014029197A1 3h-1,2-dithiocyclopentene-3-thioketone compounds and application thereof
02/27/2014WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/27/2014WO2014028968A1 Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
02/27/2014WO2013190137A3 Novel anti-cancer thiophene compounds
02/27/2014US20140058117 Process for the synthesis of substituted gamma lactams
02/27/2014US20140058100 Tetrahydroisoquinolin-1-one derivative or salt thereof
02/27/2014US20140057957 Novel Thiophene Inhibitors of S-Nitrosoglutathione Reductase
02/27/2014US20140057942 Novel rock inhibitors
02/27/2014US20140057920 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014US20140057916 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
02/27/2014US20140057915 Kinase inhibitors
02/27/2014US20140057910 Heterocyclic aspartyl protease inhibitors
02/26/2014EP2699563A1 Novel pesticidal pyrazole compounds
02/26/2014EP2699553A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
02/26/2014CN103608332A Pyridin-2-amides useful as CB2 agonists
02/26/2014CN103601722A Novel antineoplastic compounds
02/26/2014CN103601718A O-formammidotiazol-benzamide derivatives based on ryanodine receptor, and preparation method and applications thereof
02/26/2014CN103601676A Synthetic method for high-enantioselectivity N-acetyl-2-substitued-2, 3-dihydro-4-quinolinone compounds
02/26/2014CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases
02/26/2014CN102372692B 二氢吡啶衍生物 Dihydropyridine derivatives
02/25/2014US8658674 Thiophene analogues for the treatment or prevention of flavivirus infections
02/25/2014CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
02/20/2014WO2014028803A1 Substituted pyrazoles as n-type calcium channel blockers
02/20/2014WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions
02/20/2014WO2014028343A1 Solid forms of an antiviral compound
02/20/2014WO2014028342A1 Synthesis of an antiviral compound
02/20/2014WO2014028341A1 Synthesis of an antiviral compound
02/20/2014WO2014027053A1 Benzimidazoles for the treatment of cancer
02/20/2014WO2014026997A1 2,3-benzodiazepines
02/20/2014WO2014026882A1 Azaheterocycles as bir2 and/or bir3 inhibitors
02/20/2014WO2014026244A1 Photoactive optoelectronic and transistor devices
02/20/2014US20140051867 Synthesis of an antiviral compound
02/20/2014US20140051866 Synthesis of an antiviral compound
02/20/2014US20140051857 Heterocyclic compounds and thrombopoietin receptor activators
02/20/2014US20140051749 Solid forms of an antiviral compound
02/20/2014US20140051711 Compounds that modulate intracellular calcium
02/20/2014US20140051687 Substituted indole compounds having nos inhibitory activity
02/20/2014US20140051682 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 523